Keyphrases
CYP2C19 Polymorphism
85%
Percutaneous Coronary Intervention
70%
CYP2C19
63%
Genotype-guided Antiplatelet Therapy
60%
Pharmacogenomics
57%
Pharmacogenetics
49%
Antiplatelet Therapy
37%
Electronic Health Records
37%
Precision Medicine
35%
Selective Serotonin Reuptake Inhibitors
35%
Alternative Therapy
35%
Cytochrome P450 2D6 (CYP2D6)
33%
Genotype
31%
Clinical Decision Support
28%
Clopidogrel
28%
Pharmacogenetic Testing
27%
Clinical Practice
26%
Gain-of-function mutation
25%
Clinical Genetics
22%
Confidence Interval
21%
Antidepressants
20%
Adverse Drug Reaction
20%
Clinical Pharmacogenetics Implementation Consortium
20%
Drug Therapy
18%
Bleeding
18%
Therapy Selection
17%
P2Y12 Inhibitors
17%
Cardiovascular Events
16%
Turnaround Time
16%
Reusability
15%
Genotype Data
15%
Retrospective Cohort Study
15%
SLC6A4
15%
Serotonin Reuptake Inhibitor Antidepressants
15%
Pain Management
15%
Genetic Determinants
15%
Antiepileptic Drugs
15%
Bleeding Outcomes
15%
Racial Disparities
15%
Clinical Setting
15%
Treatment Response
15%
Risk Factors
15%
Therapy Outcome
15%
Targeted Drugs
15%
Anti-dementia Drugs
15%
Machine Learning
15%
HTR2A
15%
Clinical Considerations
15%
Targeted Treatment
15%
Cardiovascular Outcomes
15%
Medicine and Dentistry
CYP2C19
100%
Antiplatelet
83%
Percutaneous Coronary Intervention
56%
Allele
54%
Pharmacogenomics
36%
Pharmacogenetic Testing
35%
Electronic Health Record
32%
Drug Therapy
31%
Medicine
30%
Clopidogrel
28%
Pharmacogenetics
23%
Genotype
23%
CYP2D6
18%
Prasugrel
16%
Ticagrelor
16%
Cardiovascular System
16%
Personalized Medicine
15%
Adverse Drug Reaction
15%
Epidemic
15%
Racial Disparity
15%
Genetic Selection
15%
Opiate
15%
Isoenzyme
15%
Bleeding
15%
Selective Serotonin Reuptake Inhibitor
15%
COVID-19
15%
Hazard Ratio
13%
Antidepressant
11%
Clinician
10%
Ciclonicate
9%
Odds Ratio
7%
Analgesia
7%
Logistic Regression Analysis
7%
Health System
7%
CYP2C9
7%
Prospective Study
6%
Major Bleeding
6%
Cardiac Dysrhythmia
5%
Antidepressant
5%
CYP2B6
5%
Chi Square Test
5%
Pharmacology, Toxicology and Pharmaceutical Science
CYP2C19
81%
Antiplatelet
72%
Clopidogrel
53%
Selective Serotonin Reuptake Inhibitor
45%
Pharmacogenetics
33%
Pharmacogenomics
32%
Bleeding
21%
Prasugrel
19%
Ticagrelor
19%
Adverse Drug Reaction
17%
Cohort Study
17%
Disease
15%
Alzheimer's Disease
15%
Tolerability
15%
Coronavirinae
15%
Isoenzyme
15%
Warfarin
15%
Heart Arrhythmia
15%
Serotonin Transporter
15%
Antidepressant
13%
Mirtazapine
12%
Cardiovascular Disease
11%
Adverse Event
10%
HLA B15 Antigen
9%
Major Adverse Cardiac Event
9%
Heart Infarction
7%
Ciclonicate
6%
CYP2D6
6%
Prospective Study
5%
